Thomas Gerlach

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.

Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.

Journal: Emerging microbes & infections

Published: July 01, 2024

Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.

Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.

Journal: Vaccines

Published: November 29, 2023

Predicting absolute aqueous solubility by applying a machine learning model for an artificially liquid-state as proxy for the solid-state.

Predicting absolute aqueous solubility by applying a machine learning model for an artificially liquid-state as proxy for the solid-state.

Journal: Journal of computer-aided molecular design

Published: March 23, 2023

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection.

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection.

Journal: Frontiers in immunology

Published: March 09, 2023

Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice.

Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice.

Journal: Frontiers in immunology

Published: March 01, 2023

Infections with highly pathogenic avian influenza A virus (HPAIV) H5N8 in harbor seals at the German North Sea coast, 2021.

Infections with highly pathogenic avian influenza A virus (HPAIV) H5N8 in harbor seals at the German North Sea coast, 2021.

Journal: Emerging microbes & infections

Published: February 17, 2022

Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise.

Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise.

Journal: Vaccines

Published: July 17, 2020

Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.

Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.

Journal: Scientific reports

Published: June 29, 2020

Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination.

Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: June 12, 2019

Recombinant influenza A viruses as vaccine vectors.

Recombinant influenza A viruses as vaccine vectors.

Journal: Expert review of vaccines

Published: February 20, 2019

Response Modifiers: Tweaking the Immune Response Against Influenza A Virus.

Response Modifiers: Tweaking the Immune Response Against Influenza A Virus.

Journal: Frontiers in immunology

Published: January 10, 2019

Broadly protective influenza vaccines: design and production platforms.

Broadly protective influenza vaccines: design and production platforms.

Journal: Current opinion in virology

Published: October 26, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026